Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

December 1, 2022; Volume 63,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Hofman, Michael

    1. You have access
      Leading in Urology and Pioneering in Social Media Outreach
      Declan Murphy, Ken Herrmann and Michael Hofman
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1783-1785; DOI: https://doi.org/10.2967/jnumed.122.265028
  2. Hogdall, Claus

    1. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic
      You have access
      First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
      Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen and Andreas Kjaer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1871-1879; DOI: https://doi.org/10.2967/jnumed.122.264068
  3. Hojgaard, Liselotte

    1. You have access
      A Long Axial Field of View Enables PET/CT in Toddler Without Sedation
      Michala Reichkendler, Flemming L. Andersen, Lise Borgwardt, Ulrikka Nygaard, Elisabeth Albrecht-Beste, Kim F. Andersen, Anna Ljunggren, Nynne Abrahamsen, Annika Loft, Liselotte Højgaard and Barbara M. Fischer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1962; DOI: https://doi.org/10.2967/jnumed.121.263626
  4. Holm, Søren

    1. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic
      You have access
      First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
      Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen and Andreas Kjaer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1871-1879; DOI: https://doi.org/10.2967/jnumed.122.264068
  5. Hoppner, Jorge

    1. Repetitive Early <sup>68</sup>Ga-FAPI PET Acquisition Comparing <sup>68</sup>Ga-FAPI-02, <sup>68</sup>Ga-FAPI-46, and <sup>68</sup>Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      You have access
      Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1844-1851; DOI: https://doi.org/10.2967/jnumed.122.264069
  6. Horn, Thomas

    1. Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      You have access
      Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1809-1814; DOI: https://doi.org/10.2967/jnumed.121.263707
  7. Huang, Yiyun

    1. Evaluation of (<em>rac</em>)-, (<em>R</em>)-, and (<em>S</em>)-<sup>18</sup>F-OF-NB1 for Imaging GluN2B Subunit–Containing <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptors in Nonhuman Primates
      You have access
      Evaluation of (rac)-, (R)-, and (S)-18F-OF-NB1 for Imaging GluN2B Subunit–Containing N-Methyl-d-Aspartate Receptors in Nonhuman Primates
      Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Achi Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey and Yiyun Huang
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1912-1918; DOI: https://doi.org/10.2967/jnumed.122.263977
  8. Huber, Peter E.

    1. Repetitive Early <sup>68</sup>Ga-FAPI PET Acquisition Comparing <sup>68</sup>Ga-FAPI-02, <sup>68</sup>Ga-FAPI-46, and <sup>68</sup>Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      You have access
      Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1844-1851; DOI: https://doi.org/10.2967/jnumed.122.264069
  9. Hubert, Alexander

    1. Repetitive Early <sup>68</sup>Ga-FAPI PET Acquisition Comparing <sup>68</sup>Ga-FAPI-02, <sup>68</sup>Ga-FAPI-46, and <sup>68</sup>Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      You have access
      Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1844-1851; DOI: https://doi.org/10.2967/jnumed.122.264069
  10. Hughes, Zoë A.

    1. First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      You have access
      First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoë A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike and Robert B. Innis
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1919-1924; DOI: https://doi.org/10.2967/jnumed.122.263838
« Previous (Pages : 7 8 9 10 11 12 13 14 15 16 ... 31) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (12)
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
  • Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire